Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
暂无分享,去创建一个
Apilak Worachartcheewan | Virapong Prachayasittikul | Chanin Nantasenamat | Veda Prachayasittikul | Supaluk Prachayasittikul | Ratchanok Pingaew | Somsak Ruchirawat | C. Nantasenamat | V. Prachayasittikul | V. Prachayasittikul | S. Ruchirawat | A. Worachartcheewan | Supaluk Prachayasittikul | R. Pingaew
[1] J. Champoux. DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.
[2] J. Benites,et al. Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents. , 2010, European journal of medicinal chemistry.
[3] P. Mailley,et al. Electrochemistry and bioactivity relationship of 6-substituted-4H-pyrido[4,3,2-kl]acridin-4-one antitumor drug candidates. , 2012, Bioelectrochemistry.
[4] C. Hansch,et al. Elucidation of structure-activity relationships for 2- or 6-substituted-5,8-dimethoxy-1,4-naphthoquinones. , 2004, Bioorganic & medicinal chemistry.
[5] P. Shukla,et al. 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents. , 2009, European journal of medicinal chemistry.
[6] Claus Jacob,et al. Deciphering intracellular targets of organochalcogen based redox catalysts , 2012 .
[7] N. Osheroff,et al. Etoposide quinone is a redox-dependent topoisomerase II poison. , 2011, Biochemistry.
[8] Sheng-Tung Huang,et al. Efficient synthesis of 'redox-switched' naphthoquinone thiol-crown ethers and their biological activity evaluation. , 2002, Bioorganic & medicinal chemistry.
[9] J. Minna,et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.
[10] Bernadette A. Thomas,et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[11] K. C. Majumdar,et al. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. , 1977, Biochemical and biophysical research communications.
[12] J. Raffetto,et al. The structure of streptonigrin semiquinone in solution. , 1997, Biochimica et biophysica acta.
[13] B. Cavalcanti,et al. 1,2,3-triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones. , 2014, Bioorganic & medicinal chemistry.
[14] P. O'Brien. Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.
[15] S. Kuo,et al. Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents. , 2002, Chemical & pharmaceutical bulletin.
[16] JAMES C. Wang,et al. Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.
[17] Y. Yun,et al. Inhibitory Effects of J78, a Newly Synthesized 1,4-Naphthoquinone Derivative, on Experimental Thrombosis and Platelet Aggregation , 2004, Pharmacology.
[18] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[19] Chartchalerm Isarankura-Na-Ayudhya,et al. Advances in computational methods to predict the biological activity of compounds , 2010, Expert opinion on drug discovery.
[20] L. Liu,et al. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.
[21] Daniel N. Santiago,et al. Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors. , 2010, Bioorganic & medicinal chemistry.
[22] S. Kaufmann. Cell death induced by topoisomerase-targeted drugs: more questions than answers. , 1998, Biochimica et biophysica acta.
[23] N. Osheroff. Eukaryotic topoisomerase II. Characterization of enzyme turnover. , 1986, The Journal of biological chemistry.
[24] C. Nantasenamat,et al. QSAR study of amidino bis-benzimidazole derivatives as potent anti-malarial agents against Plasmodium falciparum , 2013, Chemical Papers.
[25] Corwin Hansch,et al. QSAR and ADME. , 2004, Bioorganic & medicinal chemistry.
[26] B. J. Roberts,et al. Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues. , 1984, Cancer research.
[27] E. Shults,et al. Inhibition of HIV-1 Reverse Transcriptase by Aryl-Substituted Naphto- and Anthraquinones , 2004, Doklady Biochemistry and Biophysics.
[28] A. Hakura,et al. Mutagenicity and cytotoxicity of naphthoquinones for Ames Salmonella tester strains. , 1994, Chemical research in toxicology.
[29] K. Hande,et al. Topoisomerase II inhibitors. , 2006, Cancer chemotherapy and biological response modifiers.
[30] James B. Mitchell,et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.
[31] Apilak Worachartcheewan,et al. Predicting antimicrobial activities of benzimidazole derivatives , 2013, Medicinal Chemistry Research.
[32] N. Osheroff,et al. DNA topoisomerase II, genotoxicity, and cancer. , 2007, Mutation research.
[33] Garry R. Buettner,et al. Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide. , 2010, Free radical biology & medicine.
[34] Pui-Kai Li,et al. Anticancer activity and SAR studies of substituted 1,4-naphthoquinones. , 2013, Bioorganic & medicinal chemistry.
[35] N. Osheroff,et al. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes. , 2003, Current topics in medicinal chemistry.
[36] T. Hamamoto,et al. A water-soluble tetrazolium salt useful for colorimetric cell viability assay , 1999 .
[37] C. Ryu,et al. The synthesis and antimicrobial activities of some 1,4-naphthoquinones (II) , 1992 .
[38] R. Hickey,et al. Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol. , 2002, Bioorganic & medicinal chemistry.
[39] V. K. Tandon,et al. Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents. , 2004, Bioorganic & medicinal chemistry letters.
[40] V. B. Konkimalla,et al. Synthesis, characterization and molecular structures of homologated analogs of 2-bromo-3-(n-alkylamino)-1,4-napthoquinone , 2014 .
[41] C. Avendaño,et al. DNA Intercalators and Topoisomerase Inhibitors , 2008 .
[42] P. Shukla,et al. Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. , 2009, European journal of medicinal chemistry.
[43] G M Cohen,et al. Quinone chemistry and toxicity. , 1992, Toxicology and applied pharmacology.
[44] Y. Yun,et al. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. , 2000, Biochemical pharmacology.
[45] C. Nantasenamat,et al. Antioxidant, cytotoxicity, and QSAR study of 1-adamantylthio derivatives of 3-picoline and phenylpyridines , 2011, Medicinal Chemistry Research.
[46] J. Bolton,et al. Role of quinones in toxicology. , 2000, Chemical research in toxicology.
[47] D. Hunting,et al. The ortho-quinone metabolite of the anticancer drug etoposide (VP-16) is a potent inhibitor of the topoisomerase II/DNA cleavable complex. , 1998, Molecular pharmacology.
[48] A. Oliveira,et al. Trypanocidal activity and redox potential of heterocyclic- and 2-hydroxy-naphthoquinones , 1997 .
[49] R. Verma. Anti-cancer activities of 1,4-naphthoquinones: a QSAR study. , 2006, Anti-cancer agents in medicinal chemistry.
[50] B. Ahn,et al. Naphthazarin derivatives (VIII): Synthesis, inhibitory effect on DNA topoisomerase‐I, and antiproliferative activity of 6‐(1‐acyloxyalkyl)‐5,8‐dimethoxy‐1,4‐naphthoquinones , 2001, Archiv der Pharmazie.
[51] N. Osheroff,et al. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. , 2000, Progress in nucleic acid research and molecular biology.
[52] F. Yoshizaki,et al. In vitro antifungal activity of naphthoquinone derivatives. , 2002, Biological & pharmaceutical bulletin.
[53] Christian Amatore,et al. Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds. , 2008, Chemical communications.
[54] P. Shukla,et al. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents. , 2006, Bioorganic & medicinal chemistry.
[55] C. Chignell,et al. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. , 2004, Chemical research in toxicology.
[56] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[57] J. B. Griffiths,et al. Mammalian cell culture : essential techniques , 1997 .
[58] V. Yardley,et al. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. , 2001, Journal of medicinal chemistry.
[59] H. Schwalbe,et al. Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes. , 2013, Journal of medicinal chemistry.
[60] Mark A. Hall,et al. Correlation-based Feature Selection for Machine Learning , 2003 .
[61] L. Pardo,et al. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line. , 2007, Journal of medicinal chemistry.
[62] P. Shukla,et al. Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents. , 2005, Bioorganic & medicinal chemistry letters.
[63] F. Emery,et al. Synthesis of quinoidal molecules: strategies towards bioactive compounds with an emphasis on lapachones. , 2013, European journal of medicinal chemistry.
[64] Chartchalerm Isarankura-Na-Ayudhya,et al. A practical overview of quantitative structure-activity relationship , 2009 .